Physician profile
William R Wolfe
NPI 1003872912
$10,994.03
in general payments reported to CMS, 2019-2025
16 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.92 · 2020: $292 · 2021: $1,515 · 2022: $1,540 · 2023: $6,977 · 2024: $242 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,038 · Food and Beverage: $960 · Travel and Lodging: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,037.50 |
| Food and Beverage | $960.40 |
| Travel and Lodging | $568.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,846.39 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Biohaven Pharmaceuticals, INC. | $513.72 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $346.59 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $264.87 | 2020-2022 | |
| Allergan, INC. | $260.83 | 2020-2022 | |
| Impel Pharmaceuticals INC. | $190.43 | 2022-2023 | Trudhesa |
| Amneal Pharmaceuticals LLC | $128.51 | 2019-2022 | |
| Medtronic, INC. | $109.69 | 2022 | |
| Lilly USA, LLC | $106.15 | 2020-2023 | Emgality, Reyvow |
| Supernus Pharmaceuticals, INC. | $47.00 | 2021 | |
| Djo, LLC | $41.65 | 2019 | |
| Electronic Waveform Lab, INC. | $41.20 | 2021-2022 | |
| Pfizer INC. | $34.70 | 2024 | |
| Neurocrine Biosciences, INC. | $29.91 | 2022 | |
| Amgen INC. | $18.30 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $14.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.